Skip to main content

Advertisement

Table 4 Adjusted hazard ratios (HR) with 95 % confidence intervals (CI) of disease-free and overall survival (n = 388)

From: L1CAM as a prognostic marker in stage I endometrial cancer: a validation study

  Disease-free survival Overall survival
  HR 95 % CI P-value HR 95 % P-value
L1CAM       
 Negative       
 Positive 2.08 0.85–5.10 0.11 1.81 0.79–4.11 0.16
FIGO stage       
 Ia       
 Ib 1.38 0.68–2.80 0.37 1.62 0.87–3.03 0.13
Age       
  < 60 years       
  > 60 years 1.85 0.75–4.54 0.18 4.15 1.46–11.7 0.01